True 2 Beauty Announces Five Million Dollar Private Placement To Increase Production Capacity of "Libigrow" Family of Products
18 October 2010 - 8:32PM
Marketwired
True 2 Beauty, Inc. (PINKSHEETS: TRTB) (the "Company"), a leading
manufacturer and distributor of male sexual potency pills and
liquid products in the United States, announced today the
"Libigrow" family of products (www.libigrow.com) will have much
larger production capacity as a result of a private placement of
five million dollars.
The financing is at $0.20 per share and no warrants are
attached. The first $2,300,000 has been subscribed and the first
wire transfer order has been received. Accredited investor
customers of True 2 Beauty and European Accredited investors are
the subscribers. The company expects to have the offering over
subscribed.
Proceeds will be used to increase the company's Los Angeles
manufacturing facility from its current one million pills per month
to twenty million pills per month.
Alex Hbaiu, President and CEO of True 2 Beauty, Inc., stated,
"This financing to expand our production will allow us to quickly
fill our order backlog and to sign new orders from customers we met
at this month's National Convenience Store Trade Show (NACS) which
has 143,000 members in the United States."
About True 2 Beauty, Inc.
True 2 Beauty, Inc. is a leading manufacturer and distributor of
male sexual potency pills and liquid products in the United States.
The True 2 Beauty, Inc. line of current products includes Libigrow,
Libigirl, Libiliquid Shots and the Libiliquid Relaxation Drink.
More information on the Company and its line of products can be
found at www.libigrow.com.
Safe Harbor Statement
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. Such statements include, among others, all assumptions,
expectations, predictions, intentions or beliefs about future
events. You are cautioned that any such forward-looking statements
are not guarantees of future performance and that a number of risks
and uncertainties could cause actual results of the Company to
differ materially from those anticipated, expressed or implied in
the forward-looking statements. The words "believe," "expect,"
"anticipate," "project," "targets," "optimistic," "intend," "aim,"
"will" or similar expressions are intended to identify
forward-looking statements. All statements other than statements of
historical fact are statements that could be deemed forward-looking
statements. Risks and uncertainties that could cause actual results
to differ materially from those anticipated include risks related
to new and existing products, product defects and any related
product recall; any projections of sales, earnings, revenue,
margins or other financial items; any statements of the plans,
strategies and objectives of management for future operations; any
statements .The Company assumes no obligation and does not intend
to update any forward-looking statements, except as required by
law.
For further information, please contact: Investors Relations
Contact: New York World Asset Management (702) 436-4562 Media
Relations: Zara Hbaiu zara@libigrow.com 1-888-942-5350
(USOTC:LEGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(USOTC:LEGX)
Historical Stock Chart
From Jul 2023 to Jul 2024